Paragard IUD Mass Tort Marketing & Case Acquisition

The litigation landscape

Federal cases are consolidated in an MDL in the Northern District of Georgia, where the litigation has matured through discovery toward bellwether workups — the stage at which settlement posture historically forms in device MDLs. The core liability story is failure to warn: the fracture risk appears in adverse event data reaching back years before the label meaningfully addressed removal breakage.

Claim quality turns on the operative record: a documented fracture during removal, imaging showing retained fragments, and the retrieval procedure that followed. That paper trail makes Paragard one of the cleaner screening exercises in device litigation.

Who a campaign targets

Screening criteria in Paragard matters typically include:

• Paragard IUD placement documented in medical records
• Device fracture at or after removal — arms breaking, fragments retained in the uterus
• Medical intervention to address the fragments: imaging, hysteroscopy, surgical retrieval, or hysterectomy
• Claims within the applicable limitations period, generally running from the fracture and retrieval events

How MTAA runs Paragard IUD campaigns

The audience is precise: women who had a copper IUD removed and experienced complications — an experience specific enough that creative describing it screens itself. Meta's reach into women's health audiences, run with the platform-policy care that category demands, produces qualified inquiries because the fact pattern is unmistakable to the women who lived it.

MTAA's Paragard campaigns screen on the three record-provable facts — placement, fracture, retrieval — so intake files arrive ready for records requests.

Buying Paragard IUD case leads vs. running your own campaign

Most firms first see Paragard IUD offered by a vendor selling case leads or signed cases at a fixed price per case. That price bundles the advertising, the vendor's intake and the vendor's margin, and the firm usually cannot see which ad the claimant answered, what it promised, or what was said at signup.

Running your own Paragard IUD campaign turns that around. The firm pays the actual Meta media cost plus a 15% management fee, owns every signed retainer and its lead data, and can audit the ad, the landing page and the screening questions behind each claimant. When a defendant or a bar inquiry asks how a plaintiff was found, the firm has the record instead of a vendor's word.